98 related articles for article (PubMed ID: 17043021)
1. The expression of PRDI-BF1 beta isoform in multiple myeloma plasma cells.
Ocaña E; González-García I; Gutiérrez NC; Mora-López F; Brieva JA; Campos-Caro A
Haematologica; 2006 Nov; 91(11):1579-80. PubMed ID: 17043021
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of the osteoblast function in multiple myeloma through the repressor gene E4BP4 activated by malignant plasma cells.
Silvestris F; Cafforio P; De Matteo M; Calvani N; Frassanito MA; Dammacco F
Clin Cancer Res; 2008 Oct; 14(19):6081-91. PubMed ID: 18829486
[TBL] [Abstract][Full Text] [Related]
3. Atypical FOXP1 expression in malignant plasma cells that show several simultaneous translocations.
Korać P; Skrtić A; Peran I; Ventura RA; Dominis M
Histopathology; 2009 May; 54(6):770-1. PubMed ID: 19438754
[No Abstract] [Full Text] [Related]
4. Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma.
Borson ND; Lacy MQ; Wettstein PJ
Blood; 2002 Dec; 100(13):4629-39. PubMed ID: 12453881
[TBL] [Abstract][Full Text] [Related]
5. Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines.
Györy I; Fejér G; Ghosh N; Seto E; Wright KL
J Immunol; 2003 Mar; 170(6):3125-33. PubMed ID: 12626569
[TBL] [Abstract][Full Text] [Related]
6. Positive regulatory domain I binding factor 1 silences class II transactivator expression in multiple myeloma cells.
Ghosh N; Gyory I; Wright G; Wood J; Wright KL
J Biol Chem; 2001 May; 276(18):15264-8. PubMed ID: 11279146
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis in plasma cells by B lymphocyte-induced maturation protein-1 knockdown.
Lin FR; Kuo HK; Ying HY; Yang FH; Lin KI
Cancer Res; 2007 Dec; 67(24):11914-23. PubMed ID: 18089822
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of HOXB7 gene in multiple myeloma and extramedullary multiple myeloma patients.
Novak EM; Linardi C; Metzger M; Maria DA; Giorgi RR; Moura F; Martinez GA; Bydlowski SP
Eur J Haematol; 2010 Feb; 84(2):185-6. PubMed ID: 19878270
[No Abstract] [Full Text] [Related]
9. Gene amplification and overexpression of PRDM14 in breast cancers.
Nishikawa N; Toyota M; Suzuki H; Honma T; Fujikane T; Ohmura T; Nishidate T; Ohe-Toyota M; Maruyama R; Sonoda T; Sasaki Y; Urano T; Imai K; Hirata K; Tokino T
Cancer Res; 2007 Oct; 67(20):9649-57. PubMed ID: 17942894
[TBL] [Abstract][Full Text] [Related]
10. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.
Korać P; Peran I; Skrtić A; Ajduković R; Kristo DR; Dominis M
Pathol Int; 2009 May; 59(5):354-8. PubMed ID: 19432679
[TBL] [Abstract][Full Text] [Related]
11. Plasma cell differentiation and multiple myeloma.
Shapiro-Shelef M; Calame K
Curr Opin Immunol; 2004 Apr; 16(2):226-34. PubMed ID: 15023417
[TBL] [Abstract][Full Text] [Related]
12. PU.1 regulates positive regulatory domain I-binding factor 1/Blimp-1 transcription in lymphoma cells.
Desai S; Bolick SC; Maurin M; Wright KL
J Immunol; 2009 Nov; 183(9):5778-87. PubMed ID: 19828640
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity.
Montero JC; López-Pérez R; San Miguel JF; Pandiella A
Haematologica; 2008 Jun; 93(6):851-9. PubMed ID: 18443272
[TBL] [Abstract][Full Text] [Related]
14. The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells.
Weinhold N; Meissner T; Johnson DC; Seckinger A; Moreaux J; Försti A; Chen B; Nickel J; Chubb D; Rawstron AC; Doughty C; Dahir NB; Begum DB; Young K; Walker BA; Hoffmann P; Nöthen MM; Davies FE; Klein B; Goldschmidt H; Morgan GJ; Houlston RS; Hose D; Hemminki K
Haematologica; 2015 Mar; 100(3):e110-3. PubMed ID: 25480495
[No Abstract] [Full Text] [Related]
15. The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myeloma.
Sarasquete ME; García-Sanz R; Armellini A; Fuertes M; Martín-Jiménez P; Sierra M; Del Carmen Chillón M; Alcoceba M; Balanzategui A; Ortega F; Hernández JM; Sureda A; Palomera L; González M; San Miguel JF
Haematologica; 2006 Nov; 91(11):1551-4. PubMed ID: 17043023
[TBL] [Abstract][Full Text] [Related]
16. Transcription of PRDM1, the master regulator for plasma cell differentiation, depends on an SP1/SP3/EGR-1 GC-box.
Mora-López F; Pedreño-Horrillo N; Delgado-Pérez L; Brieva JA; Campos-Caro A
Eur J Immunol; 2008 Aug; 38(8):2316-24. PubMed ID: 18604866
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a novel repressor of beta-interferon gene expression.
Keller AD; Maniatis T
Genes Dev; 1991 May; 5(5):868-79. PubMed ID: 1851123
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients.
Paiva B; Gutiérrez NC; Chen X; Vídriales MB; Montalbán MÁ; Rosiñol L; Oriol A; Martínez-López J; Mateos MV; López-Corral L; Díaz-Rodríguez E; Pérez JJ; Fernández-Redondo E; de Arriba F; Palomera L; Bengoechea E; Terol MJ; de Paz R; Martin A; Hernández J; Orfao A; Lahuerta JJ; Bladé J; Pandiella A; Miguel JF;
Leukemia; 2012 Aug; 26(8):1862-9. PubMed ID: 22333880
[TBL] [Abstract][Full Text] [Related]
19. Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.
Chandesris MO; Soulier J; Labaume S; Crinquette A; Repellini L; Chemin K; Malphettes M; Fieschi C; Asli B; Uzunhan Y; Fermand JP; Bories JC; Arnulf B
Br J Haematol; 2007 Feb; 136(4):609-14. PubMed ID: 17223917
[TBL] [Abstract][Full Text] [Related]
20. Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage I.
Gastinne T; Leleu X; Duhamel A; Moreau AS; Franck G; Andrieux J; Lai JL; Coiteux V; Yakoub-Agha I; Bauters F; Harousseau JL; Zandecki M; Facon T;
Eur J Haematol; 2007 Oct; 79(4):297-304. PubMed ID: 17692103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
